Literature DB >> 9176983

Tobacco use among young adults in Norway, 1973-95: has the decrease levelled out?

P Kraft1, T Svendsen.   

Abstract

OBJECTIVE: To describe the prevalence of tobacco use among young Norwegian adults, 1973-1995.
DESIGN: Cross sectional personal and telephone surveys.
SETTING: Norway, 1973-1995. PARTICIPANTS: Population based samples of Norwegians aged 16-74 years.
RESULTS: A trend to a decline in tobacco use among young adult Norwegians during the 1960s and 1970s levelled out during the 1980s. Hence, the total prevalence of smoking in Norway decreased by only two percentage points from 1980 to 1993, as compared to approximately 10 percentage points in many other European countries. An increase in smoking prevalence (and in the use of snuff among males) in the age group 16-19 years has been observed in recent years. Thus smoking prevalence among young males and females in 1995 was comparable to that observed in the early 1980s.
CONCLUSIONS: Trends in tobacco use reflect an underutilization of preventive measures in general, and health education measures in particular. Financial resources appropriated for health education and information were reduced by 90% during the 1980s.

Entities:  

Mesh:

Year:  1997        PMID: 9176983      PMCID: PMC1759536          DOI: 10.1136/tc.6.1.27

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  3 in total

1.  Tobacco reduction: a continued health promotion challenge.

Authors:  C Mangham
Journal:  Can J Public Health       Date:  1999 Mar-Apr

2.  Adolescent smoking and exposure to tobacco marketing under a tobacco advertising ban: findings from 2 Norwegian national samples.

Authors:  Marc T Braverman; Leif Edvard Aarø
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

3.  Oral health behavior patterns among Tanzanian university students: a repeat cross-sectional survey.

Authors:  Anne Nordrehaug Åstrøm; Joyce Rose Masalu
Journal:  BMC Oral Health       Date:  2001       Impact factor: 2.757

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.